CARLA LAUREANO LAL: Open Payments
NPI 1457078701 · NYACK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$257 in 6 payments from 5 companies in 2025. Trend: 2023 $1,977 · 2024 $700 · 2025 $257
Food & beverage: $257
| Company | Payments | Amount |
|---|---|---|
| Legend Biotech USA Inc. | 1 | $117 |
| GENZYME CORPORATION | 2 | $57 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $30 |
| SANOFI-AVENTIS U.S. LLC | 1 | $28 |
| AstraZeneca Pharmaceuticals LP | 1 | $24 |
Products named: CARVYKTI, SARCLISA, NINLARO, REZUROCK, ENHERTU.
Industry payments across NY — which companies pay providers there.
